Who
Adrian R. Krainer
Director
Company insider
Files Form 4 as: Director, Stoke Therapeutics.
In numbers
- Trades disclosed
- 16
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $5.5M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 10 Sep 2019
- Last trade
- 3 Jun 2026
- Last filed
- 5 Jun 2026
Companies traded
Activity over time
1 Nov 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 5 Jun 2026 | STOK Stoke Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,786 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | STOK Stoke Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,786 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.3M33,243 at $39.74 | filing |
| 10 Mar 2026filed 12 Mar 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.3M33,243 at $39.74 | filing |
| 2 Mar 2026filed 4 Mar 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $287K7,229 at $39.66 | filing |
| 2 Mar 2026filed 4 Mar 2026 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $287K7,229 at $39.66 | filing |
| 24 Nov 2025filed 26 Nov 2025 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.2M40,472 at $29.72 | filing |
| 14 Nov 2025filed 18 Nov 2025 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $527K19,790 at $26.61 | filing |
| 14 Nov 2025filed 18 Nov 2025 | STOK Stoke TherapeuticsBiotechnology | SEC FORM 4 Sold | $565K20,682 at $27.34 | filing |
| 3 Jun 2025filed 4 Jun 2025 | STOK Stoke Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,747 at $0.00 | filing |
| 5 Jun 2024filed 7 Jun 2024 | STOK Stoke Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,639 at $0.00 | filing |
| 13 Jun 2023filed 15 Jun 2023 | STOK Stoke Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,441 at $0.00 | filing |
| 7 Jun 2022filed 8 Jun 2022 | STOK Stoke Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,000 at $0.00 | filing |
| 8 Jun 2021filed 25 Jun 2021 | STOK Stoke Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,650 at $0.00 | filing |
| 3 Jun 2020filed 5 Jun 2020 | STOK Stoke Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,777 at $0.00 | filing |
| 10 Sep 2019filed 12 Sep 2019 | STOK Stoke Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,777 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.